Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-18-027713)

Filing Details

Accession Number:: 0001140361-18-027713
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-06-07 17:07:08
Reporting Period:: 2018-06-05

Accepted Time:: 2018-06-07 17:07:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367644	Emergent Biosolutions Inc.	EBS	Pharmaceutical Preparations (2834)	141902018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380187	Daniel Abdun-Nabi	400 Professional Dr, Suite 400 Gaithersburg MD 20879	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-06-05	15,785	$52.11	197,343	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,936	Indirect	By Son

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.83 to $52.66. inclusive.
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.